more on universal red blood cells
Two families of enzymes that could remove the blood group A, B and AB antigens from the surface of red blood cells have just been identified by the Architecture and Function of Biological Macromolecules Laboratory (CNRS – Université Aix-Marseille 1 and 2), in collaboration with ZymeQuest Inc. These two families of enzymes have unique properties and are so efficient that large scale conversion of blood groups A, B and AB into universal donor group O is feasible.
A general view of the molecular structure of Elizabethkingia meningosepticum N-acetylgalactosaminidase in complex with the NAD+ cofactor (in yellow) and the A antigen on the surface of A type red blood cells. The N-acetylgalactosamine molecule recognized and hydrolyzed by the enzyme appears in red. (Credit: Copyright AFMB – CNRS 2007)
The difficulty entailed in carrying sufficient stocks of certain blood groups is well known, for example in the case of seasonal variation or a sudden increase in demand following a disaster. So the possibility of converting blood groups would solve these problems by making a significant improvement in the supply of group O.
The new enzymes, discovered after detailed exploration of the great diversity of known bacteria available, come from bacteria with sometimes unlikely names such as Elizabethkingia, (Queen Elizabeth). These enzymes can remove the galactose or N-acetylgalactosamine molecules present on the surface of the red blood cells characterizing the A, B and AB antigens. The prohibitive cost and low efficiency of previously known enzymes meant that using them for blood group conversion was not viable. But these new enzymes have an unusual catalytic mechanism that changes that.
The Architecture and Function of Biological Macromolecules Laboratory uses X-ray crystallography to study the 3-D structures of the enzymes and classify them according to their amino acid sequence. This database, known as CAZy (Carbohydrate-Active Enzymes), has many applications worldwide including discovering genes in the genome structure. Researchers use structural data to identify the architecture of active sites and understand their mechanism of action. The aim is to create tools which, in this case, improve enzyme efficiency.
Reference: Bacterial glycosidases for the production of universal red blood cells, Qiyong P Liu, Gerlind Sulzenbacher, Huaiping Yuan, Eric P Bennett, Greg Pietz, Kristen Saunders, Jean Spence, Ed Nudelman, Steven B. Levery, Thayer White, John M. Neveu, Williams Lane, Yves Bourne, Martin L Olsson, Bernard Henrissat, Henrik Clausen, Nature Biotechnology, April 2007